Endocrine / Hormonal
Lanreotide
Lanreotide is a long-acting somatostatin analog primarily utilized for the management of acromegaly and neuroendocrine tumors.
Evidence: 0 articles
Goals: 0
Mechanism of Action
Lanreotide functions as a synthetic octapeptide analog of natural somatostatin. It exerts its primary physiological effects by binding with high affinity to human somatostatin receptors (SSTR), specifically subtypes 2 and 5. This binding inhibits the secretion of various hormones, including growth hormone (GH), insulin, and glucagon, and modulates the release of neuroendocrine mediators.
Evidence Level
Clinical Trial - Human
0 studies published
Pharmacology
Molecular Weight
1096.3 Da